The frequencies of CYP2C19*2, *3, and *17 alleles and their impact on the clinical efficacy of doubled maintenance dose of clopidogrel in Syrian patients with coronary artery disease

Table 5 Distribution of recurrent cardiac ischemic events by CYP2C192* polymorphism

Allele CYP2C192*	Refractory angina symptoms		P value	Major adverse cardiac events		P value
Allele CYP2C192*	Yes	No	P value	Yes	No	P value
Yes	2 (%33.33)	4 (%66.67)	>0.9999	1 (%16.67)	5 (%83.33)	0.2744
No	14 (%38.89)	22 (%61.11)	>0.9999	1 (%2.86)	34 (%97.14)	0.2744

ISSN: 1471-2261